share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/22 16:15
Moomoo AI 已提取核心訊息
Applied UV, Inc. has received a notification from the Nasdaq Listing Qualifications Staff on May 16, 2024, indicating that the company's common stock did not meet the minimum closing bid price of $1.00 per share over a 31 consecutive business day period from April 3, 2024, to May 15, 2024. This requirement is a condition for continued listing on The Nasdaq Capital Market under the Nasdaq Listing Rule 5550(a)(2). The company has been granted an initial 180-day compliance period, ending on November 12, 2024, to address and rectify the bid price deficiency. If Applied UV fails to regain compliance within this timeframe, it may be eligible for an additional 180-day period, provided it meets certain conditions, including the possibility of a reverse stock split. Failure to comply within the...Show More
Applied UV, Inc. has received a notification from the Nasdaq Listing Qualifications Staff on May 16, 2024, indicating that the company's common stock did not meet the minimum closing bid price of $1.00 per share over a 31 consecutive business day period from April 3, 2024, to May 15, 2024. This requirement is a condition for continued listing on The Nasdaq Capital Market under the Nasdaq Listing Rule 5550(a)(2). The company has been granted an initial 180-day compliance period, ending on November 12, 2024, to address and rectify the bid price deficiency. If Applied UV fails to regain compliance within this timeframe, it may be eligible for an additional 180-day period, provided it meets certain conditions, including the possibility of a reverse stock split. Failure to comply within the granted periods could lead to the delisting of the company's common stock from The Nasdaq Capital Market. However, the notice does not immediately affect the listing of Applied UV's common stock, which will continue to trade under the symbol 'AUVI'. The company is currently exploring options to regain compliance, but there is no certainty that it will achieve this or maintain other Nasdaq listing requirements. The report was signed by Mike Riccio, Chief Financial Officer of Applied UV, Inc., on May 22, 2024.
Applied UV, Inc.已於2024年5月16日收到納斯達克上市資格工作人員的通知,表明該公司的普通股在2024年4月3日至2024年5月15日的連續31個工作日內未達到每股1.00美元的最低收盤價。該要求是根據納斯達克上市規則5550(a)(2)繼續在納斯達克資本市場上市的條件。該公司已獲准最初的180天合規期,該合規期將於2024年11月12日結束,以解決和糾正投標價格缺陷。如果Applied UV未能在這段時間內恢復合規性,則可能有資格再延長180天,前提是它滿足某些條件,包括反向股票拆分的可能性。未能在授權期限內遵守規定可能會導致該公司的普通股從納斯達克資本市場退市。但是,該通...展開全部
Applied UV, Inc.已於2024年5月16日收到納斯達克上市資格工作人員的通知,表明該公司的普通股在2024年4月3日至2024年5月15日的連續31個工作日內未達到每股1.00美元的最低收盤價。該要求是根據納斯達克上市規則5550(a)(2)繼續在納斯達克資本市場上市的條件。該公司已獲准最初的180天合規期,該合規期將於2024年11月12日結束,以解決和糾正投標價格缺陷。如果Applied UV未能在這段時間內恢復合規性,則可能有資格再延長180天,前提是它滿足某些條件,包括反向股票拆分的可能性。未能在授權期限內遵守規定可能會導致該公司的普通股從納斯達克資本市場退市。但是,該通知並未立即影響Applied UV普通股的上市,該普通股將繼續以'AUVI'的代碼進行交易。該公司目前正在探索恢復合規性的備選方案,但尚不確定是否會實現這一目標或維持其他納斯達克上市要求。該報告由應用紫外光公司首席財務官邁克·裏西奧於2024年5月22日簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息